Welcome to our dedicated page for Mannatech SEC filings (Ticker: MTEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mannatech filings document the regulatory record for an operating health and wellness company that sells nutritional supplements, skin care and anti-aging products, and weight-management products through an independent associate and member network. Periodic and current reports disclose operating results, net sales, gross profit, commissions, foreign currency effects, regional demand, supply chain costs and customer and associate activity.
The company's SEC record also includes proxy materials covering director elections, auditor ratification and executive compensation votes; 8-K reports on financial results and leadership changes; Form 12b-25 late-filing notices; and disclosures related to Nasdaq continued-listing standards and stockholders' equity. These filings describe governance, capital-structure matters, reporting status and risk areas relevant to MTEX common stock.
Mannatech Inc director Robert Toth received a new stock option grant. He was awarded the right to purchase 5,000 shares of Mannatech common stock at an exercise price of $5.77 per share, expiring on June 3, 2036.
According to the vesting terms, one-third of the options vest on the grant date, another one-third on the first anniversary, and the final one-third on the second anniversary. After this grant, Toth holds rights to purchase a total of 8,334 shares of Mannatech common stock directly.
Mannatech Inc director John A. Seifrick received a grant of stock options representing the right to purchase 5,000 shares of common stock at an exercise price of $5.77 per share. One-third of these options vest on the grant date, another one-third on the first anniversary, and the final third on the second anniversary of the grant date.
After this award, Seifrick directly holds rights to acquire a total of 11,807 shares. The award reflects equity-based compensation rather than an open-market stock purchase or sale.
Mannatech, Incorporated reported that shareholders approved all proposals at the 2026 annual shareholders’ meeting held on June 2, 2026. Proxies representing 1,369,880 shares, or 71.0% of the 1,929,670 shares outstanding as of the April 6, 2026 record date, were voted.
Shareholders elected Class III directors John A. Seifrick and Robert Toth, with 879,504 and 937,930 votes for, respectively, and broker non-votes of 277,128 for each. They also ratified BDO USA, P.C. as independent auditor for 2026 and approved, on an advisory basis, executive compensation.
Mannatech, Inc. director Larry A. Jobe bought additional company stock in the open market. On May 20, 2026, he purchased 2,803 shares of Mannatech common stock at a weighted average price of $4.12 per share, with individual trade prices of $4.15 and $4.03.
After this transaction, Jobe directly owns 70,000 Mannatech shares. The filing notes that the reported price is a weighted average across multiple trades and that detailed trade-by-trade pricing is available on request.
MANNATECH INC director Larry A. Jobe reported an open-market purchase of the company’s common stock. He bought 5,000 shares on May 19, 2026 at a price of $4.20 per share. Following this transaction, he directly holds 67,197 shares of Mannatech common stock.
Mannatech, Inc. director Kevin Andrew Robbins bought additional company stock in the open market. On May 19, 2026, he purchased 7,100 shares of common stock at a weighted average price of $4.17 per share, with trade prices ranging from $4.10 to $4.22. Following these purchases, he directly owns 33,333 shares of Mannatech common stock.
Mannatech, Incorporated reported a return to profitability for the first quarter of 2026. Net sales were $24.9M, down from $26.6M a year earlier, but cost controls and other income led to net income of $0.95M versus a net loss of $1.53M in 2025.
Gross profit was $18.9M and loss from operations narrowed to $0.18M, compared with a $0.83M operating loss a year ago. Diluted earnings per share improved to $0.49 from a diluted loss per share of $0.80, while the company also highlighted constant currency non-GAAP metrics to show underlying trends.
Mannatech, Inc. reported Q1 2026 net sales of $24.9 million, down 6.2% from a year earlier, but swung to net income of $0.95 million versus a prior loss. Gross margin improved to 75.7% on higher pricing and lower inventory charges, and operating cash flow turned positive at $1.1 million. Cash and cash equivalents were $7.0 million with working capital of $1.7 million. However, management discloses conditions that raise substantial doubt about the company’s ability to continue as a going concern and notes noncompliance with a Nasdaq stockholders’ equity requirement. Management is pursuing cost reductions, capital discipline, margin initiatives, and revenue stabilization to address these challenges.
Mannatech, Incorporated has been notified by Nasdaq that it no longer meets the Nasdaq Capital Market’s stockholders’ equity requirement. Nasdaq Listing Rule 5550(b)(1) calls for minimum stockholders’ equity of $2,500,000, but Mannatech reported stockholders’ equity (deficit) of ($5,223,000) as of December 31, 2025, a shortfall of about $7.7 million.
The company also fails alternative continued listing standards tied to market value of listed securities and net income from continuing operations. Mannatech has 45 days from the April 20, 2026 notice, until June 4, 2026, to submit a plan to regain compliance and could receive up to October 17, 2026 to demonstrate compliance if Nasdaq accepts the plan. If Nasdaq rejects the plan, Mannatech may appeal to a Nasdaq Hearings Panel. Beginning April 27, 2026, Nasdaq will identify the company as non-compliant on its website and market data feeds.
Mannatech, Incorporated director Robert Toth has filed a Schedule 13D reporting a 5.1% ownership stake in the company’s common stock. He beneficially owns 99,254 shares, based on 1,929,670 shares outstanding, and holds sole voting and dispositive power over all of these shares.
The position arises from an unrestricted stock grant awarded as part of Mannatech’s director compensation arrangements, with no cash consideration paid by Toth. He states the shares are held for investment and equity compensation purposes and indicates no current plans for major corporate actions, and no additional contracts or arrangements concerning Mannatech securities beyond those described.